Small molecule · Inhibitor of HMG-CoA reductase (HMGCR) · developed by Astrazeneca
Rosuvastatin is a statin that selectively and competitively inhibits HMG-CoA reductase, the rate-limiting enzyme that converts HMG-CoA to mevalonate, a precursor of cholesterol. It lowers hepatic cholesterol and increases LDL cholesterol uptake.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT02772640 | Phase 4 | Hypercholesterolemia | Completed | COLL |
| NCT07930507 | Phase 3 | Hypercholesterolemia | Not yet recruiting | AZN |
| NCT07216482 | Phase 3 | Hyperlipidemia | Completed | MRK |
| NCT06834932 | Phase 2/3 | Dyslipidaemia | Active not recruiting | AZN |
| NCT07820891 | Phase 1 | Healthy Adult Participants | Recruiting | ONC |
| NCT07534592 | Phase 1 | Healthy Participants | Active not recruiting | AZN |
| NCT07372625 | Phase 1 | TP53 Y220C Mutation | Recruiting | PMVP |
| NCT07339722 | Phase 1 | Healthy | Recruiting | LLY |
| NCT06917508 | Phase 1 | RSV Infection | Completed | ENTA |
| NCT06717269 | Phase 1 | Healthy Volunteer | Completed | NRIX |
| NCT06191991 | Phase 1 | Healthy Volunteers | Completed | ALGS |
| NCT05652660 | Phase 1 | Healthy | Completed | ARVN |
| NCT05154123 | Phase 1 | Healthy Volunteer Study | Completed | AVIR |
| NCT04608344 | Phase 1 | Rheumatoid Arthritis | Completed | LKFT |
| NCT03136237 | Phase 1 | Hereditary Angioedema | Completed | BCRX |
| NCT02542969 | Phase 1 | Healthy | Completed | MDGL |
| NCT02300363 | Phase 1 | Healthy | Completed | LXRX |
| NCT02140281 | Phase 1 | Healthy Volunteers | Completed | ARDX |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Advanced Solid TumorsDyslipidaemiaHealthy Adult ParticipantsHealthy ParticipantsTP53 Y220C MutationCystic FibrosisDrug Drug InteractionHealthyHealthy VolunteerHealthy Volunteer StudyHereditary AngioedemaHypercholesterolemiaRheumatoid ArthritisRSV Infection
Updated Nov 15, 2026. Something wrong or missing? Report it on the AZN page.
See AZN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
AZN catalysts and pipeline →